Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,409 | 486 | 63.1% |
| Travel and Lodging | $7,270 | 21 | 36.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $3,927 | 13 | $0 (2022) |
| AERIN MEDICAL INC. | $2,170 | 24 | $0 (2024) |
| Intersect ENT, Inc. | $2,111 | 30 | $0 (2022) |
| Medtronic USA, Inc. | $2,084 | 137 | $0 (2020) |
| Acclarent, Inc | $1,704 | 53 | $0 (2023) |
| Entellus Medical, Inc. | $1,702 | 15 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $1,468 | 58 | $0 (2024) |
| GlaxoSmithKline, LLC. | $990.71 | 39 | $0 (2024) |
| Medical Device Business Services, Inc. | $826.00 | 7 | $0 (2022) |
| Optinose US, Inc. | $487.62 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,813 | 56 | AERIN MEDICAL INC. ($1,956) |
| 2023 | $1,185 | 37 | AstraZeneca Pharmaceuticals LP ($287.32) |
| 2022 | $5,580 | 53 | Medtronic, Inc. ($3,891) |
| 2021 | $1,766 | 51 | Intersect ENT, Inc. ($432.60) |
| 2020 | $826.30 | 62 | Medtronic USA, Inc. ($240.35) |
| 2019 | $1,326 | 82 | Medtronic USA, Inc. ($371.49) |
| 2018 | $1,218 | 89 | Acclarent, Inc ($296.52) |
| 2017 | $4,964 | 77 | Entellus Medical, Inc. ($1,702) |
All Payment Transactions
507 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $17.59 | General |
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.30 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $1.50 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $86.13 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: EAR NOSE & THROAT | ||||||
| 09/25/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $120.51 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.54 | General |
| Category: Immunology | ||||||
| 08/21/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $1.32 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Respiratory | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Respiratory | ||||||
| 08/03/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device) | Travel and Lodging | Cash or cash equivalent | $117.49 | General |
| Category: EAR NOSE & THROAT | ||||||
| 07/31/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device) | Food and Beverage | Cash or cash equivalent | $117.15 | General |
| Category: EAR NOSE & THROAT | ||||||
| 07/24/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device) | Travel and Lodging | In-kind items and services | $721.95 | General |
| Category: EAR NOSE & THROAT | ||||||
| 07/24/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device) | Travel and Lodging | In-kind items and services | $253.12 | General |
| Category: EAR NOSE & THROAT | ||||||
| 07/24/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device) | Travel and Lodging | In-kind items and services | $30.99 | General |
| Category: EAR NOSE & THROAT | ||||||
| 07/24/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: EAR NOSE & THROAT | ||||||
| 07/24/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device) | Travel and Lodging | In-kind items and services | $26.93 | General |
| Category: EAR NOSE & THROAT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,379 | 2,360 | $698,610 | $303,120 |
| 2022 | 29 | 1,644 | 2,641 | $918,636 | $416,560 |
| 2021 | 30 | 1,921 | 3,180 | $958,786 | $425,532 |
| 2020 | 21 | 1,457 | 2,383 | $686,371 | $264,394 |
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2023 | 92 | 212 | $149,636 | $59,271 | 39.6% |
| 31298 | Dilation of sphenoid and frontal nasal sinus using an endoscope | Office | 2023 | 16 | 16 | $124,800 | $58,093 | 46.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 334 | 716 | $80,908 | $41,888 | 51.8% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 162 | 287 | $71,750 | $36,953 | 51.5% |
| J3490 | Unclassified drugs | Office | 2023 | 13 | 13 | $37,206 | $28,177 | 75.7% |
| 31295 | Dilation of nasal sinus using an endoscope | Office | 2023 | 16 | 16 | $54,400 | $27,465 | 50.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 80 | 80 | $20,000 | $9,617 | 48.1% |
| 31238 | Control of bleeding of nose using an endoscope | Office | 2023 | 17 | 23 | $9,775 | $6,330 | 64.8% |
| 69145 | Removal of growth in soft tissue of ear canal | Office | 2023 | 14 | 19 | $15,783 | $5,701 | 36.1% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 42 | 49 | $12,364 | $4,539 | 36.7% |
| 92567 | Test to assess middle ear function | Office | 2023 | 152 | 310 | $11,362 | $3,755 | 33.1% |
| 30520 | Reshaping of nasal cartilage | Office | 2023 | 14 | 14 | $18,720 | $3,577 | 19.1% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 125 | 230 | $17,250 | $2,782 | 16.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $6,650 | $2,777 | 41.8% |
| 30140 | Removal of nasal air passage under lining tissue | Office | 2023 | 15 | 15 | $13,936 | $2,563 | 18.4% |
| 70486 | Ct scan of face without contrast | Office | 2023 | 34 | 34 | $17,000 | $2,010 | 11.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 42 | 56 | $3,864 | $1,862 | 48.2% |
| 92570 | Comprehensive hearing test | Office | 2023 | 54 | 54 | $4,050 | $1,144 | 28.2% |
| 70480 | Ct scan of cranial cavity without contrast | Office | 2023 | 17 | 17 | $10,200 | $1,097 | 10.8% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2023 | 36 | 36 | $3,466 | $849.21 | 24.5% |
| 17250 | Application of chemical to stop tissue regrowth in wound | Office | 2023 | 19 | 24 | $3,798 | $806.86 | 21.2% |
| 30930 | Therapeutic fracture of nasal passages | Office | 2023 | 15 | 15 | $3,992 | $678.00 | 17.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 16 | 16 | $4,000 | $608.48 | 15.2% |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | Office | 2023 | 16 | 70 | $3,700 | $576.23 | 15.6% |
| 31298 | Dilation of sphenoid and frontal nasal sinus using an endoscope | Office | 2022 | 27 | 27 | $210,600 | $103,203 | 49.0% |
About Dr. Hamid Obeid, MD
Dr. Hamid Obeid, MD is a Otolaryngology healthcare provider based in Rome, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1548251663.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hamid Obeid, MD has received a total of $19,679 in payments from pharmaceutical and medical device companies, with $2,813 received in 2024. These payments were reported across 507 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($12,409).
As a Medicare-enrolled provider, Obeid has provided services to 6,401 Medicare beneficiaries, totaling 10,564 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Practice Information
- Specialty Otolaryngology
- Location Rome, NY
- Active Since 10/31/2005
- Last Updated 09/15/2023
- Taxonomy Code 207Y00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1548251663
Products in Payments
- PROPEL (Device) $4,711
- VIVAER STYLUS (Device) $2,133
- XprESS Multi-Sinus Dilation System (Device) $1,702
- FUSION (Device) $982.89
- NUVENT (Device) $885.27
- SINUVA (Drug) $826.60
- NUCALA (Biological) $799.26
- DUPIXENT (Biological) $758.30
- Xhance (Drug) $487.62
- BREZTRI (Drug) $463.70
- ACCLARENT Balloon Inflation Device (Device) $423.61
- SYMBICORT (Drug) $390.89
- Acclarent Navwire (Device) $349.67
- Otovel (Drug) $336.38
- Acclarent Aera (Device) $298.19
- BEVESPI AEROSPHERE (Drug) $286.38
- ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $218.43
- FASENRA (Biological) $188.93
- Acclarent ENT Navigation System (Device) $160.91
- TRELEGY ELLIPTA (Drug) $159.69
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Rome
Brandon Miller, Md, MD
Otolaryngology — Payments: $298.44
Robert King, Md, MD
Otolaryngology — Payments: $242.67
Mary Beauchamp, M.d, M.D
Otolaryngology — Payments: $229.19
Toby Morgan, M.d.06, M.D.06
Otolaryngology
Dr. David Rodriguez, M.d, M.D
Otolaryngology
Jacqueline Crupi, Md, MD
Otolaryngology